1. Severe Hepatic Side Effects of Ezetimibe
Mark F.J. Stolk, Marco C.J.M. Becx, Karel C. Kuypers, Cees A. Seldenrijk 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 7, Pages (July 2006)
DOI: /j.cgh
Copyright © 2006 American Gastroenterological Association Terms and Conditions

2. Figure 1
Laboratory values of patient 1. Week 0 was the time of presentation at the outpatient clinic. alat, alanine aminotransferase; AP, alkaline phosphatase; bili, bilirubin.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

3. Figure 2
Mild mononuclear inflammatory infiltrate with a mild lobular component (H&E stain, magnification 100×).
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

4. Figure 3
Laboratory values of patient 2. Ezetimibe was used from weeks 6–19. alat, alanine aminotransferase; AP, alkaline phosphatase; bili, bilirubin.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

5. Figure 4
Extensive chronic inflammatory infiltrate with plasma cells and eosinophils with a strong lobular component; stage 3 fibrosis (A, H&E stain, magnification 200×; B, reticulin stain, magnification 200×).
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions